Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsNeoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorderRecruitingPhase 12026-10-05NCT06784193

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Olema Pharmaceuticals, Inc.5

25 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Banner Md Anderson Cancer CenterGilbertUnited States121
Cancer Research South AustraliaAdelaideAustralia11
Dana-Farber Cancer InstituteBostonUnited States626
Florida Cancer SpecialistsSarasotaUnited States47
Hôpital Paris Saint-JosephParisFrance1
Institut De Cancerologie De L'ouestSaint-HerblainFrance1
Institut Gustave RoussyVillejuifFrance2
Liverpool HospitalLiverpoolAustralia66
Macquarie University Clinical Trials UnitMacquarieAustralia2
Massachusetts General HospitalBostonUnited States1015
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Queen Mary HospitalHong KongHong Kong11
Scri Oncology PartnersNashvilleUnited States156
START - BarcelonaBarcelonaSpain1
Start - FjdMadridSpain1
START - MidwestGrand RapidsUnited States5
START - Mountain RegionWest Valley CityUnited States2
START - San AntonioSan AntonioUnited States7
START DublinDublinIreland1
START Madrid - CIOCCMadridSpain1
Tennessee OncologyNashvilleUnited States77
The Kinghorn Cancer CentreDarlinghurstAustralia2
The Ohio State UniversityColumbusUnited States2
University Medical Center - New OrleansNew OrleansUnited States3
University of ColoradoAuroraUnited States147